文献速递泌尿生殖腹部CT

CT检测前列腺外周带前列腺癌的诊断价值

Diagnostic Value of CT in Detecting Peripheral Zone Prostate Cancer.
PubMed 文献 · AJR Am J Roentgenol · 2019-06-19

回顾性分析100例经活检证实的前列腺癌患者与100例年龄匹配的男性对照,评估增强CT发现前列腺外周带局灶性异常强化对诊断前列腺癌的效能。结果显示敏感度0.83、特异度0.92、阳性预测值0.91、阴性预测值0.84,不同Gleason评分者诊断准确率无显著差异,读者间一致性Cohen kappa为0.76。

要点

  • 增强CT上前列腺外周带局灶性异常强化区可能代表临床显著前列腺癌。
  • 以经直肠超声引导活检为参考标准,CT诊断敏感度0.83、特异度0.92。
  • 不同Gleason评分者之间CT诊断准确率无显著差异。

核心结论

  • 增强CT上偶然发现的前列腺外周带局灶性强化区可能代表临床显著前列腺癌,值得进一步检测前列腺特异性抗原并结合前列腺癌临床危险因素进行分析。

研究设计与样本

  • 回顾性分析纳入2010年1月至2017年12月经活检证实的前列腺癌患者100例,均于诊断后3个月内行腹盆部增强CT;对照组为同期随机选取的100例年龄匹配、无已知恶性肿瘤病史的男性门诊患者,同样行腹盆部增强CT;两名读者在不知分组的情况下独立评估前列腺外周带局灶性异常强化的可能性。

关键影像表现/征象

  • 增强CT上评估前列腺癌的依据为前列腺外周带局灶性异常强化。
  • 两名读者对癌症患者和对照患者的评估一致性Cohen kappa为0.76。

诊断标准与关键数值

  • 以经直肠超声引导活检为参考标准,CT诊断敏感度0.83、特异度0.92、阳性预测值0.91、阴性预测值0.84。
  • 100例活检证实的前列腺癌患者中83例被正确识别,100例对照中92例被正确识别。

临床应用与阅片要点

  • 作者认为,增强CT上偶然发现的前列腺外周带局灶性强化区可能代表临床显著前列腺癌,值得进一步检测前列腺特异性抗原并结合前列腺癌临床危险因素进行分析。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this study was to identify the sensitivity of contrast-enhanced CT in detecting high-grade prostate adenocarcinoma. MATERIALS AND METHODS. A retrospective analysis included 100 patients with prostate cancer proven by biopsy between January 2010 and December 2017 who underwent staging CT of the abdomen and pelvis within 3 months of diagnosis. The control subjects were 100 randomly selected aged-matched male outpatients with no known history of malignancy who underwent contrast-enhanced CT of the abdomen and pelvis in the same time period as the patients with cancer. Two readers, blinded to both groups, independently assessed the likelihood of prostate cancer on the basis of the CT finding of focal abnormally increased peripheral enhancement in the prostate. Binary classification of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) was used to assess the diagnostic utility of CT versus the reference standard of transrectal ultrasound-guided biopsy. RESULTS. Eighty-three of 100 patients with biopsy-proven prostate cancer and 92 of 100 control subjects were correctly identified (sensitivity, 0.83; specificity, 0.92; PPV, 0.91; NPV, 0.84). There was no significant difference in diagnostic accuracy among subjects with different Gleason scores. Interrater agreement on both the cancer and control patients was 0.76 as assessed by Cohen kappa statistic. CONCLUSION. Incidental detection of a focal area of increased enhancement in the periphery of the prostate at contrast-enhanced CT may represent a clinically significant cancer and deserves further workup with prostate-specific antigen measurement and correlation with clinical risk factors for prostate cancer.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Huang G, Lebovic G, Vlachou PA, et al. Diagnostic Value of CT in Detecting Peripheral Zone Prostate Cancer. AJR Am J Roentgenol. 2019. PMID: 31216196. doi:10.2214/AJR.18.21013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。